This study further explored patient-reported health-related quality of life (HRQOL), functioning, symptoms, and symptom tolerability in CAPItello-291. This phase 3, randomised, double-blind, placebo-controlled trial, which was conducted across 193 hospitals and cancer centres in 19 countries, ...
HER2 - Negative Breast Cancer - Global Strategic Business Report Report 205 Pages May 2025 Global From €5340 About the Market The HER2 Negative Breast Cancer Drug market is a subset of the larger Breast Cancer Drug market. HER2 Negative Breast Cancer Drugs are used to treat breast cancer that...
Caitlin Lewis, Senior Vice President of Strategy & Mission, Living Beyond Breast Cancer, said: “Only one in three patients with metastatic HR-positive, HER2-negative breast cancer live more than five years following diagnosis, highlighting the urgent need for additional effective therapies. The appr...
Metastatic breast cancer (MBC) remains incurable in most patients; the goals of treatment are to optimize quality of life, manage symptoms and prolong survival. A wide array of agents is available for the treatment of MBC, including endocrine therapies, cytotoxic chemotherapy (Table 1) and targete...
frequently in the first 4 weeks of treatment. If you are not sure how to test your blood sugar levels, talk to your healthcare provider. You should stay well-hydrated during treatment with Itovebi. Tell your healthcare provider right away if you develop symptoms of high blood sugar, ...
[2]. Hence, there is an urgent need to develop metastatic breast cancer treatment that prolongs patient’s survival, alleviates symptoms, and improves the quality of life (QoL) [3]. Currently, the Japanese Breast Cancer Society recommends anthracyclines, taxanes, and S-1 as the first-line ...
The efficacy of adjuvant endocrine therapy for hormone receptor-positive breast cancer has been previously established. However, significant adverse events
In the case of advanced disease where two other drugs have been tried, the antibody-drug conjugate sacituzumab govitecan (Trodelvy) may be tried. Get an overview ontriple-negative breast cancersymptoms and treatment.
Abbreviations AC, doxorubicin and cyclophosphamide; AML, acute myeloid leukaemia; ATS, acute transition symptoms; BCSS, breast cancer specific survival; CEA, cost effectiveness analysis; CEAC, cost-effectiveness acceptability curves; CHEERS, Consolidated Health Economic Evaluation Reporting Standards; CHF, ...
HER2, human epidermal growth factor receptor 2; HR, hormone receptor; IV, intravenous; mBC, metastatic breast cancer; Pts, patients; TNBC, triple-negative breast cancer. The Institutional Review Board of each investigational site approved the study before its initiation, and all patients provided wr...